Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
7(33%)
Results Posted
36%(4 trials)

Phase Distribution

Ph phase_3
4
19%
Ph not_applicable
10
48%
Ph phase_2
4
19%

Phase Distribution

0

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution18 total trials
Phase 2Efficacy & side effects
4(22.2%)
Phase 3Large-scale testing
4(22.2%)
N/ANon-phased studies
10(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

21

all time

Status Distribution
Active(7)
Completed(11)
Other(3)

Detailed Status

Completed11
Active, not recruiting6
unknown2
Suspended1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
7
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (22.2%)
Phase 34 (22.2%)
N/A10 (55.6%)

Trials by Status

suspended15%
completed1152%
recruiting15%
unknown210%
active_not_recruiting629%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT03838419Not Applicable

Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer

Suspended
NCT01266642Phase 2

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Active Not Recruiting
NCT00907868Not Applicable

Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS)

Active Not Recruiting
NCT04871516Not Applicable

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer

Active Not Recruiting
NCT06954831Phase 2

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

Recruiting
NCT02003209Phase 3

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

Completed
NCT00769379Phase 3

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Completed
NCT01556243Phase 2

Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer

Completed
NCT03269981Not Applicable

Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer

Active Not Recruiting
NCT00909909Phase 2

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Active Not Recruiting
NCT04842409

Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery

Completed
NCT01407770

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Completed
NCT00103181Not Applicable

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

Completed
NCT04148586Not Applicable

Trial Comparing 3 Schedules of Hypofractionated Whole Breast Irradiation in Females With Early Stage Breast Cancer

Completed
NCT03616626Not Applicable

Whole Breast Irradiation vs Twice Daily vs. Once Daily Accelerated Partial Breast Irradiation

Unknown
NCT00003855Phase 3

Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer

Completed
NCT00892814Not Applicable

Partial Breast Versus Whole Breast Irradiation in Elderly Women Operated on for Early Breast Cancer

Active Not Recruiting
NCT01803958Not Applicable

Breast Cancer With Low Risk Of Local Recurrence: Partial and Accelerated Radiation With Three-Dimensional Conformal Radiotherapy (3DCRT) Vs. Standard Radiotherapy After Conserving Surgery (Phase III Study

Completed
NCT00282035Not Applicable

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Completed
NCT03568981

Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer

Unknown

Drug Details

Intervention Type
RADIATION
Total Trials
21